(0.07%) 5 520.75 points
(0.11%) 39 886 points
(0.18%) 19 787 points
(-0.01%) $81.62
(0.43%) $2.82
(-0.31%) $2 337.10
(0.05%) $29.54
(0.32%) $1 005.00
(0.02%) $0.932
(0.00%) $10.53
(0.01%) $0.788
(-0.85%) $87.25
1.28% $ 0.790
Live Chart Being Loaded With Signals
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States...
Stats | |
---|---|
Dzisiejszy wolumen | 1.85M |
Średni wolumen | 613 314 |
Kapitalizacja rynkowa | 56.05M |
EPS | $-0.170 ( Q1 | 2024-05-14 ) |
Następna data zysków | ( $-0.220 ) 2024-08-02 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-1.100 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00200 (0.26%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-18 | Levin Jeremy M | Buy | 18 248 | Common Stock |
2024-02-22 | Tardio Jason | Buy | 168 750 | Stock Option (Right to Buy) |
2024-02-22 | Tardio Jason | Buy | 28 125 | Common Stock |
2024-02-22 | Rona Jeffrey A | Buy | 28 125 | Common Stock |
2024-02-22 | Rona Jeffrey A | Buy | 168 750 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
28.01 |
Last 96 transactions |
Buy: 16 581 029 | Sell: 7 414 277 |
Wolumen Korelacja
Ovid Therapeutics Inc Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Ovid Therapeutics Inc Korelacja - Waluta/Towar
Ovid Therapeutics Inc Finanse
Annual | 2023 |
Przychody: | $391 695 |
Zysk brutto: | $-1.20M (-307.61 %) |
EPS: | $-0.740 |
FY | 2023 |
Przychody: | $391 695 |
Zysk brutto: | $-1.20M (-307.61 %) |
EPS: | $-0.740 |
FY | 2022 |
Przychody: | $1.50M |
Zysk brutto: | $121 142 (8.06 %) |
EPS: | $-0.730 |
FY | 2021 |
Przychody: | $208 383 |
Zysk brutto: | $208 383 (100.00 %) |
EPS: | $0.00182 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Ovid Therapeutics Inc
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, and Northwestern University, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej